A complicated story involving Novartis’s valsartan (Diovan) has led to the retraction of two more papers, one cascading from the other. Last September, The Lancet retracted the Jikei Heart Study after a slew of retractions of related work prompted an investigation of valsartan research. That investigation found evidence of data manipulation and the failure of … Continue reading Novartis Diovan scandal claims two more papers
In the wake of Harvard’s gritty performance in the NCAA men’s basketball tournament — they were eliminated Saturday — a pair of faculty members at the Ivy League institution are calling foul on two controversial journal articles that have already been corrected. Walter Willett, an oft-quoted Harvard nutrition expert, is calling for the retraction of … Continue reading March Madness? Harvard profs take shots at controversial studies, request retractions
If you were gathering references to write a paper, or just keeping studies in an online library, wouldn’t it be nice to get an alert any time any of those papers was retracted? Well, now you can. We’re very pleased to announce that PubChase, a free biomedical literature search and recommendation tool, will now feature … Continue reading Want alerts about retractions of papers in your library? Check out PubChase
Chemist Sanjeeb Kumar Sahoo, of the Institute of Life Sciences in Bhubaneswar, India, has earned his sixth retraction for image shennanigans, this time in Applied Materials & Interfaces. Sahoo, as we reported last year, had lost five articles in Acta Biomaterialia for what the journal called “highly unethical practices.” The latest retraction involves an article … Continue reading SK Sahoo notches sixth retraction
Another busy week here at Retraction Watch, with many in the scientific world glued to their browsers for more information on the latest stem cell controversy. Hear Ivan on the BBC discussing what that story means for post-publication peer review. Elsewhere around the web:
Another busy week at Retraction Watch, including a ScienceOnline 2014 session Ivan facilitated on post-publication peer review. Here’s a selection of what was happening elsewhere on the web:
An international team of researchers from the NIH, Harvard, the University of Michigan, and two Chinese universities — Fourth Military Medical University and China Medical University — has retracted their 2012 paper in Nature after they — and a number of other groups — were unable to reproduce the key results. The original abstract for … Continue reading Nature paper retracted following multiple failures to reproduce results
An article in New Space, a journal about space travel, has been retracted because the results it presented weren’t ready for liftoff. The retraction notice appears as a letter from editor G. Scott Hubbard:
Yet another busy week at Retraction Watch, with one of us taking part in a symposium on the future of science journalism for a few days. (See if you can find Ivan in this picture.) Here’s what was happening elsewhere on the web in science publishing and related issues:
AAPS PharmSciTech, a journal of the American Association of Pharmaceutical Scientists, has retracted a 2013 paper by a group from India. The reason appears to be manipulated data, although the wording of the notice leaves that open to interpretation. The article, “Design and Formulation Technique of a Novel Drug Delivery System for Azithromycin and Its … Continue reading Pharmaceutical journal retracts antibiotics paper with dodgy data, with an unclear notice